Walmart Settles DOJ Opioid Suit, Amount Secret

Walmart Settles DOJ Opioid Suit, Amount Secret

The News

Walmart has settled the federal lawsuit accusing it of unlawfully dispensing opioids from its pharmacies, the Justice Department confirmed Friday.

Neither Walmart nor the department disclosed how much the retailer is paying.

The suit, filed in December 2020, alleged Walmart violated the Controlled Substances Act by filling thousands of invalid prescriptions and failing to report suspicious drug orders at the height of the opioid epidemic.

Timeline

December 2020

After a multiyear investigation, the Justice Department files a nationwide lawsuit against Walmart under the Controlled Substances Act, alleging the company's pharmacies filled thousands of invalid prescriptions and that it failed to report suspicious orders.

November 2022

Walmart separately agrees to pay $3.1 billion to resolve claims by state and local governments over its pharmacies' role in the opioid crisis, according to the Financial Times.

August 28, 2026

Walmart and the Justice Department confirm a settlement of the federal case. The amount is not released.

Reactions

"We are pleased to resolve this matter and will continue supporting the exceptional work our pharmacists do every day to provide outstanding patient care," a Walmart spokesman said in an email to CBS News.

The Justice Department framed the deal as part of a broader enforcement push. "We will continue to hold accountable companies and individuals whose unlawful prescribing, marketing, dispensing or distributing practices contributed to the opioid crisis and put American communities at risk," a department spokesman said.

What's Next

With the federal case resolved, the dollar figure is the open question — settlement terms in Controlled Substances Act cases are typically spelled out in court filings and department announcements, but neither side has released one here.

Walmart continues to operate nearly 4,600 pharmacies nationwide, filling prescriptions for generic drugs, insulin, GLP-1 medications and other treatments, according to the company's website.

More

The exposure Walmart avoided was enormous. If the company had been held liable, the Justice Department said it would have faced $67,627 for each unlawful prescription filled and $15,691 for each suspicious order it failed to report — penalties multiplied across thousands of alleged violations.

Federal prosecutors tied that conduct to a national death toll: more than 800,000 Americans died of opioid overdoses between 1999 and 2023, according to the Justice Department's account of the epidemic.

Colleges Condemn Students Mocking Kirk Assassination Anniversary

Charleston White Arrested Again on Florida Battery Charge

Border Patrol Rescues MS NOW Crew in Desert

Supreme Court Restores Missouri's Old House Map

Alaska Drops Felony Voter Charges Against Samoans

Trespasser Breaches Harris' Malibu Estate; No Arrest

Hegseth Pressed Downed Airmen Into 60 Minutes

Houthis Seize Mokha, Choking Saudi Oil Exports

Altman Rules Out OpenAI IPO This Year

Jury Acquits Lil Durk in Murder-for-Hire Case

Judge: Trump Broke Law Halving FEMA Staff

Maher Calls Democrats' Gaza Genocide Claim a Lie

Blizzard Revives StarCraft, Sends Diablo to Netflix

Trump's Queens Childhood Home Sells for $1.93M

Scientists Find New Virus in Tick Invading US

Britain Bans Settlement Imports; US States Threaten Payback

Prison Fire Kills 7 as Kurds Protest Killing

Kosovo Rallies for Ex-President Before Hague Verdict

Cruz Booed at GameDay Over College Sports Bill

Blast Hits Bulgarian Arms Plant Supplying Ukraine